Stock listing
Xetra:BRM Bristol-Myers Squibb Company Aktie
German listing (Xetra) of Bristol-Myers Squibb Company · home listing NYSE:BMY
Follow Bristol-Myers Squibb Company into a list and get an email when it puts out news.
Share price · XETR:BRM
€56.65 EUR -0.29 (-0.5%)
Close on Nov 13, 2026
- Day range
- €56.61 – €56.97 EURNov 13, 2026
- Volume
- 132 sharesNov 13, 2026
- Market cap
- €115.7B EURAt the close on Nov 13, 2026 · price × 2.04B shares outstanding
- 52-week range
- €39.22 – €61.19 EURLowest and highest trades, Nov 14, 2025 – Nov 13, 2026
- Traded on an average day
- €60,594 EURMedian day 667 shares · last 3 months, Aug 13, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:BMY · Home | $63.43 USD | +1.11 (+1.8%) | 9,273,620 | $62.56 | $63.78 | $61.81 | $62.32 | Close on Nov 13, 2026 |
| Xetra:BRM | €56.65 EUR | -0.29 (-0.5%) | 132 | €56.97 | €56.97 | €56.61 | €56.94 | Close on Nov 13, 2026 |
| BMV:BMY | $1,149.00 MXN | +9.00 (+0.8%) | 338 | $1,149.00 | $1,149.00 | $1,149.00 | $1,140.00 | Close on Nov 11, 2026 |
| B3:BMYB34 | 353.53 BRL | +10.18 (+3.0%) | 4 | 353.53 | 353.53 | 353.53 | 343.35 | Close on Nov 12, 2026 |
| Frankfurt:BRM | €56.80 EUR | -0.14 (-0.2%) | 40 | €56.11 | €56.80 | €55.89 | €56.94 | Close on Nov 13, 2026 |
| Munich:BRM | €56.76 EUR | 0.00 (0.0%) | — | €56.76 | €56.76 | €56.76 | €56.76 | Close on Nov 13, 2026 |
| Hamburg:BRM | €56.65 EUR | -0.25 (-0.4%) | — | €56.51 | €56.65 | €56.51 | €56.90 | Close on Nov 13, 2026 |
| Dusseldorf:BRM | €56.98 EUR | +0.10 (+0.2%) | — | €56.45 | €56.98 | €56.27 | €56.88 | Close on Nov 13, 2026 |
Daily closes
Last 3 months, Aug 13, 2026 – Nov 6, 2026 · XETR:BRM · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €56.00 | -0.92 | -1.6% | €56.42 | €56.42 | €55.12 | 935 | |
| €56.92 | +0.84 | +1.5% | €57.17 | €58.30 | €56.92 | 2,515 | |
| €56.08 | +0.16 | +0.3% | €54.75 | €56.43 | €54.75 | 703 | |
| €55.92 | +0.10 | +0.2% | €56.01 | €56.35 | €55.61 | 1,601 | |
| €55.82 | -0.38 | -0.7% | €55.98 | €56.18 | €55.14 | 2,210 | |
| €56.20 | +1.94 | +3.6% | €55.45 | €57.00 | €55.45 | 885 | |
| €54.26 | +0.06 | +0.1% | €55.21 | €55.40 | €53.83 | 3,501 | |
| €54.20 | -0.91 | -1.7% | €54.98 | €55.57 | €54.20 | 919 | |
| €55.11 | +0.39 | +0.7% | €54.96 | €55.11 | €54.96 | 230 | |
| €54.72 | -0.43 | -0.8% | €54.68 | €55.24 | €54.68 | 39 | |
| €55.15 | -0.93 | -1.7% | €55.93 | €56.21 | €54.82 | 1,384 | |
| €56.08 | +1.82 | +3.4% | €54.46 | €56.08 | €54.45 | 504 | |
| €54.26 | -0.40 | -0.7% | €54.74 | €54.74 | €54.26 | 537 | |
| €54.66 | +2.36 | +4.5% | €52.51 | €54.66 | €52.51 | 300 | |
| €52.30 | -1.71 | -3.2% | €52.94 | €53.05 | €52.28 | 3,642 | |
| €54.01 | -0.88 | -1.6% | €53.83 | €54.12 | €53.83 | 288 | |
| €54.89 | +2.72 | +5.2% | €53.63 | €54.91 | €53.63 | 629 | |
| €52.17 | +1.51 | +3.0% | €50.63 | €52.22 | €50.63 | 806 | |
| €50.66 | -0.57 | -1.1% | €51.43 | €51.92 | €50.30 | 1,271 | |
| €51.23 | -1.72 | -3.2% | €52.63 | €56.13 | €50.99 | 5,652 | |
| €52.95 | +0.27 | +0.5% | €53.09 | €53.26 | €52.89 | 251 | |
| €52.68 | -1.15 | -2.1% | €53.40 | €53.91 | €52.68 | 340 | |
| €53.83 | +1.16 | +2.2% | €53.35 | €53.83 | €52.82 | 475 | |
| €52.67 | +0.10 | +0.2% | €53.04 | €53.08 | €51.88 | 192 | |
| €52.57 | -1.51 | -2.8% | €54.46 | €54.49 | €52.23 | 2,640 | |
| €54.08 | -0.55 | -1.0% | €54.02 | €54.52 | €53.66 | 699 | |
| €54.63 | -1.32 | -2.4% | €55.60 | €55.77 | €54.54 | 6,314 | |
| €55.95 | +0.19 | +0.3% | €55.38 | €56.06 | €55.38 | 251 | |
| €55.76 | +0.10 | +0.2% | €56.06 | €56.48 | €55.76 | 756 | |
| €55.66 | +1.41 | +2.6% | €54.77 | €55.66 | €54.77 | 190 | |
| €54.25 | +0.66 | +1.2% | €54.01 | €54.45 | €53.82 | 158 | |
| €53.59 | -0.66 | -1.2% | €53.82 | €53.91 | €53.59 | 504 | |
| €54.25 | -0.67 | -1.2% | €54.79 | €54.84 | €54.00 | 251 | |
| €54.92 | -0.04 | -0.1% | €54.60 | €55.06 | €54.60 | 1,728 | |
| €54.96 | +0.20 | +0.4% | €54.88 | €55.25 | €54.81 | 2,418 | |
| €54.76 | -0.48 | -0.9% | €54.80 | €55.45 | €54.40 | 1,623 | |
| €55.24 | -0.21 | -0.4% | €55.61 | €55.61 | €55.12 | 153 | |
| €55.45 | +0.15 | +0.3% | €55.70 | €55.70 | €55.17 | 227 | |
| €55.30 | -0.29 | -0.5% | €55.72 | €55.72 | €54.88 | 551 | |
| €55.59 | +1.03 | +1.9% | €55.04 | €56.41 | €55.04 | 2,559 | |
| €54.56 | -0.49 | -0.9% | €54.79 | €55.24 | €54.56 | 671 | |
| €55.05 | -0.29 | -0.5% | €55.46 | €55.57 | €54.90 | 1,025 | |
| €55.34 | -0.62 | -1.1% | €55.31 | €55.78 | €55.30 | 1,415 | |
| €55.96 | -1.79 | -3.1% | €57.45 | €57.45 | €55.94 | 510 | |
| €57.75 | +0.13 | +0.2% | €57.99 | €57.99 | €57.32 | 377 | |
| €57.62 | -0.51 | -0.9% | €58.15 | €58.15 | €57.62 | 18 | |
| €58.13 | +0.32 | +0.6% | €57.91 | €58.70 | €57.75 | 1,752 | |
| €57.81 | +0.07 | +0.1% | €57.74 | €58.26 | €57.22 | 611 | |
| €57.74 | +0.47 | +0.8% | €57.40 | €58.55 | €57.40 | 1,805 | |
| €57.27 | +0.01 | 0.0% | €57.14 | €57.27 | €57.10 | 540 | |
| €57.26 | -0.37 | -0.6% | €57.64 | €57.85 | €57.11 | 136 | |
| €57.63 | -0.28 | -0.5% | €58.40 | €58.40 | €57.00 | 95 | |
| €57.91 | -0.11 | -0.2% | €58.16 | €58.50 | €57.91 | 662 | |
| €58.02 | +0.69 | +1.2% | €58.00 | €58.14 | €57.24 | 856 | |
| €57.33 | -0.30 | -0.5% | €57.91 | €57.91 | €57.00 | 345 | |
| €57.63 | +0.36 | +0.6% | €56.50 | €57.66 | €55.86 | 508 | |
| €57.27 | -0.53 | -0.9% | €58.01 | €58.02 | €56.70 | 1,096 | |
| €57.80 | +0.66 | +1.2% | €56.31 | €58.77 | €56.31 | 432 | |
| €57.14 | +1.52 | +2.7% | €56.30 | €57.14 | €56.30 | 1,175 | |
| €55.62 | +0.58 | +1.1% | €54.96 | €55.68 | €54.70 | 2,263 | |
| €55.04 | -1.02 | -1.8% | €55.99 | €56.12 | €54.94 | 1,136 | |
| €56.06 | +0.61 | +1.1% | €55.46 | €56.06 | €55.10 | 261 |
- Ticker
- Xetra:BRM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Xetra
- Currency
- EUR
What changed lately
Latest news release · Nov 12, 2026
Bristol Myers Squibb Announces Evolution of Research & Development Organization
Latest earnings call · Oct 29, 2026
Bristol-Myers Squibb (NYSE:BMY) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 29, 2026
Q3 2026 Earnings Presentation
Earnings · 57 slides
Calls
Replays
Bristol-Myers Squibb (NYSE:BMY) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 8:00 AM ET
Watch TranscriptBristol-Myers Squibb (NYSE:BMY) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 8:15 AM ET
Watch TranscriptBristol-Myers Squibb (NYSE:BMY) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Bristol Myers Squibb Canada Partners with TANK Worldwide and Ogilvy Health to Turn Autumn Leaves into a Guide for Spotting the Warning Signs of Melanoma
Nov 4, 2026
Closed €56.08 (+0.3%) on Nov 4, 2026
Bristol Myers Squibb Reports Third Quarter Financial Results for 2026
Oct 29, 2026
Closed €54.26 (+0.1%) on Oct 29, 2026
Izalontamab Brengitecan (Iza-Bren) Doubles Median Progression-Free Survival in Patients with Previously-Treated EGFR-Mutated Non-Small Cell Lung Cancer Compared to Chemotherapy in the Phase 3 PANKU-Lung01 Study
Oct 26, 2026
Closed €54.72 (-0.8%) on Oct 26, 2026
Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSToronto 2026
Oct 23, 2026
Closed €54.72 (-0.8%) on Oct 26, 2026
Tempus Expands Strategic Collaboration with Bristol Myers Squibb
Oct 23, 2026
Closed €55.15 (-1.7%) on Oct 23, 2026
Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study
Oct 23, 2026
Closed €55.15 (-1.7%) on Oct 23, 2026
IHI and Bristol Myers Squibb Launch National Collaborative to Expand Access to Cancer Clinical Trials
Oct 22, 2026
Closed €56.08 (+3.4%) on Oct 22, 2026
Bristol Myers Squibb to Showcase Next-Generation Cancer Modalities and Leadership Across Solid Tumors at ESMO 2026
Oct 19, 2026
Closed €52.30 (-3.2%) on Oct 19, 2026
Financings
Senior unsecured notes
Nov 5, 2025 · US$5.74B
Announced: €5B · Citigroup Global Markets Limited +4
Dealers: Citigroup Global Markets Limited (co-lead), Barclays Bank PLC (co-lead), BNP PARIBAS (co-lead), J.P. Morgan Securities plc (co-lead), Société Générale (co-lead)
Use of proceeds: With about $3.0 billion cash on hand, to fund the tender offer for outstanding notes, pay related fees, and for general corporate purposes
Decks
Q3 2026 Earnings Presentation
Earnings · 57 slides · Oct 29, 2026
Q3 2026 Earnings Presentation
Earnings · 16 slides · Oct 29, 2026
Q2 2026 Earnings Presentation
Earnings · 57 slides · Jul 30, 2026
Q2 2026 Earnings Presentation
Earnings · 16 slides · Jul 30, 2026
Bristol-Myers Squibb Company on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 98 in the last 12 months · 152 in all · newest Nov 12, 2026 · oldest 2025
- Calls
- 32 calls with a replay · 32 with a transcript · latest Oct 29, 2026
- Decks
- 93 decks · latest Oct 29, 2026
Where Bristol-Myers Squibb Company is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:BMY · Home listing | NYSE | United States | USD |
| BCBA:BMY | BCBA | Argentina | ARS |
| gettex:BRM | gettex | Germany | EUR |
| Tradegate:BRM | Tradegate | Germany | EUR |
| Xetra:BRM · This page | Xetra | Germany | EUR |
| BMV:BMY | BMV | Mexico | MXN |
| LS Exchange:850501 | LS Exchange | Germany | EUR |
| Lang & Schwarz:850501 | Lang & Schwarz | Germany | EUR |
| Stuttgart:BRM | Stuttgart | Germany | EUR |
| BOATS:BMY | BOATS | United States | USD |
| B3:BMYB34 | B3 | Brazil | BRL |
| Milan:1BMY | Milan | Italy | EUR |
| Frankfurt:BRM | Frankfurt | Germany | EUR |
| SIX Swiss:BMY | SIX Swiss | Switzerland | CHF |
| BCBA:BMYD | BCBA | Argentina | USD |
| BIVA:BMY | BIVA | Mexico | MXN |
| SIX Swiss:BMY.USD | SIX Swiss | Switzerland | USD |
| LSIN:0R1F | LSIN | United Kingdom | USD |
| Munich:BRM | Munich | Germany | EUR |
| EUROTLX:4BMY | EUROTLX | Italy | EUR |
| Hamburg:BRM | Hamburg | Germany | EUR |
| Hanover:BRM | Hanover | Germany | EUR |
| BVL:BMYUS | BVL | Peru | PEN |
| BCBA:BMYB | BCBA | Argentina | ARS |
| Dusseldorf:BRM | Dusseldorf | Germany | EUR |
| VIE:BMYS | Vienna | Austria | EUR |
| Aquis:BRMD | Aquis | United Kingdom | EUR |
| Aquis:BRMD | Aquis | United Kingdom | EUR |
| BX Swiss:BRM | BX Swiss | Switzerland | CHF |
| BCBA:BMYC | BCBA | Argentina | USD |
| Turquoise:BMYN | Turquoise | United Kingdom | USD |
| BCBA:BMY.CI | BCBA | Argentina | ARS |
Log in to ask 6ix AI your own questions about Bristol-Myers Squibb Company.